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Abstract
Aims—To examine the correlation between the Fagerström Test for Nicotine Dependence
(FTND) score and smoking prevalence across countries.
Design—Cross-sectional study.
Setting—Fifteen studies from 13 countries with FTND score data.
Participants—Samples of smokers were identified through systematic literature searches, web
queries and colleagues. Smokers were considered representative of their country's smoking
population if they were drawn from population-based sources, were not seeking smoking cessation
treatment and did not have significant comorbidities. Smoking prevalence data were derived from
the study itself or the country's population rate of daily smoking for the study year.
Measurements—A Pearson correlation coefficient was used to examine the direction and
magnitude of the correlation between FTND score and smoking prevalence across countries.
Findings—FTND scores ranged from 2.8 to 4.6. Smokers in Germany and Norway had the
lowest FTND scores, while smokers in Sweden and the United States had the highest FTND
scores. The prevalence of daily smoking in these countries was very different: 37% and 30% in
Germany and Norway, 19% and 16% in the United States and Sweden, respectively. An inverse
correlation towards higher FTND scores in countries with lower smoking prevalence was found (r
= -0.73, P = 0.001). Current smokers had higher FTND scores than former smokers.
Conclusions—The significant inverse correlation between FTND score and smoking prevalence
across countries and higher FTND score among current smokers supports the idea that remaining
smokers may be hardening. Less dependent smokers may quit more easily and remaining
dependent smokers may need more intensive treatment.
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INTRODUCTION
For some time, smokers have been pressured to stop smoking and it has been suggested that
current smokers might be more dependent than former smokers, as less dependent smokers
can quit more easily [1]. Termed the ‘hardening hypothesis’ it is currently being debated,
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particularly in the United States, where the smoking prevalence dropped significantly over
the last decades but has plateaued in recent years [2,3]. Empirical and observational
evidence support that today's smoking population contain groups of smokers for whom it is
harder to quit, potentially because they have a higher degree of nicotine dependence. Irvin &
Brandon demonstrated that smoking quit rates have declined over time in the United States,
suggesting that today's smokers are more difficult to help [4]. Differences in personal
characteristics between current and former smokers have been reported where socio-
economic status and educational attainment are lower and psychiatric comorbidities are
higher among current smokers [2,5,6]. Consistent with this evidence, the first author (K. F.)
has observed a change in the smoking cessation patient population in Sweden since 1975.
With the continuous decline in cigarette smoking over time among Swedish men [7], he has
noticed that the remaining smokers are more likely to be single, less educated, of lower
income and report more alcohol consumption, chronic pain conditions, depression,
unemployment and sick leave. Finally, Hughes & Brandon [3] proposed that future smokers
might be more dependent and thereby contribute to a hardening of the smoking population
because the same social pressures that urge the less-dependent smokers to quit would
prevent those who find nicotine less reinforcing from starting smoking [8].
Contrary to the ‘hardening hypothesis’, O'Connor reported recently that the number of
cigarettes and nicotine intake had decreased in parallel when they compared two American
smoking populations in 1988–94 and 1999–2002 [9]. These data are inconsistent with the
hypothesis that the remaining population of smokers is becoming more dependent on
nicotine over time, as they are smoking fewer cigarettes and nicotine intake also decreased.
If there is such a thing as a ‘hardening target’ of smokers it should be examined by country,
as countries differ dramatically in their antismoking climates. In some countries, the
prevalence of cigarette smoking has just started to decline while it has more than halved in
countries such as the United States and Sweden. Antismoking climates around the world
have been assessed and countries in Europe with strong antismoking climates include
Ireland, the United Kingdom and Sweden, while the Mediterranean and German-speaking
countries generally have less developed antismoking climates [10,11].
In this report we present the available data on degree of dependence as assessed by the
Fagerström Test for Nicotine Dependence (FTND) [12] among samples of smokers from
around the world. The objectives of this report were: (i) to compile existing data on FTND
score and smoking prevalence by country; (ii) to calculate a correlation between FTND
scores and smoking prevalence across countries; and (iii) to examine whether patterns
observed in our data are consistent with the idea of a ‘hardening target’. We hypothesized
that in countries with low smoking prevalence, smokers would have higher FTND scores,
and that current smokers would have higher FTND scores than former smokers.
METHODS
We identified 15 samples of smokers with FTND score data from 13 countries through
colleagues, the US National Library of Medicine, the SRNT Listserve and Psych Info. To be
included in the analysis, samples of smokers had to contribute FTND score data and be
representative of their country's general smoking population; studies among specific
subgroups of smokers including psychiatric patients, smoking cessation trial participants or
smokers with significant comorbidities were excluded. Most of the studies we included have
been published formally as independent research papers, while other studies have been
described previously and used in a similar analysis [1].We chose to include data from three
twin registries as they are population-based, and twins exhibit similar means, frequencies
and prevalences to singletons for many traits and adult diseases [13].
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Characteristics were described for each study, including country, sample size, data
collection method, group surveyed, year of survey, age group, definition of smoker and
response rate. FTND scores could range from 0 to 10, with higher scores reflecting greater
dependence. Smoking prevalence was based on the actual prevalence of daily smoking in
the sample for most studies. For two studies, the prevalence estimates for the survey year
were obtained from the US Centers for Disease Control website, which contains smoking
prevalence estimates in the United States between 1965 and 2006 for current smokers
(http://www.cdc.gov/tobacco/data_statistics/tables/adult/table_2.htm). On a limited set of
studies, FTND score by sex and by smoking status were available, and FTND scores for ex-
smokers were based on smoking behaviour before they quit.
A Pearson correlation coefficient (r) measured the strength and direction of the linear
relationship between FTND scores and smoking prevalence for each country, while a t-test
was utilized to determine whether the correlation was statistically significant.
RESULTS
Table 1 describes the studies included in this report; 15 studies from 13 countries are
represented. Table 2 presents FTND score, smoking prevalence and survey year for each
country, and is sorted from lower to higher FTND scores. The observed FTND scores
ranged from 2.8 to 4.6 with a mean of 3.6. The lowest FTND scores (< 3) were observed in
Germany, Norway, Spain and the Netherlands, while the highest scores (> 4) were found in
Sweden and the United States. The prevalence of daily smoking at the time of the surveys in
the two extremes was also very different, with 37% and 30% in Germany and Norway and
only 19% and 16% in the United States and Sweden, respectively. The Pearson correlation
coefficient between smoking prevalence and FTND score across countries was r =-0.73, P =
0.001. The inverse correlation suggests that, as smoking prevalence decreased, FTND score
increased. Sex-specific FTND data were available only in a subset of studies; therefore
correlations were not calculated separately for males and females. However, in all instances
males had higher FTND scores than females (data not shown). Similarly, while only a few
studies reported FTND score by smoking status, in all studies current smokers had higher
FTND scores than former smokers (data not shown).
DISCUSSION
FTND scores ranged from 2.8 to 4.6 and smoking prevalence from 16 to 37%. The observed
significant inverse correlation between FTND score and smoking prevalence suggests that
countries with lower smoking prevalence had higher FTND scores.
A possible mechanism to explain the observed association is that stronger antismoking
climates (such as the United States and Sweden) may have lowered smoking prevalence by
encouraging the less dependent smokers to quit. The limited data from former smokers
support this idea, as in all studies former smokers reported lower FTND scores at the time of
smoking compared with current smokers [26]. Clearly, recall accuracy is a concern and
conclusions should be drawn carefully. However, preliminary evidence suggests that
retrospective recall of the FTND is acceptably reliable [27]. If our observed correlation is
true, remaining smokers in the future might be more dependent and require more intensive
smoking cessation treatment.
It was interesting to note that in the studies with sexspecific FTND scores, males had higher
scores than females. It is unclear whether this is a true reflection of underlying dependence
or differences in other factors. The lower FTND scores among females may be due to their
lower daily cigarette consumption, which in turn might reflect lower buying power or
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greater concerns about health [28,29]. However, females have at least the same difficulties
quitting smoking as males [30,31], and markers of smoke intake such as carbon monoxide in
exhaled air usually show the same concentration [32]. Future studies should investigate this
association further.
Differences in FTND scores alone may not explain why today's smokers may be more
difficult to help quit smoking. Differences in personal characteristics between current and
former smokers have been reported where socio-economic status and educational attainment
are lower and psychiatric comorbidities are higher among current smokers [2,5,6]. These
factors are probably relatively independent of the degree of tobacco dependence as
measured by FTND. Although genetic factors may play a role in dependence and in quitting
smoking [33], it is unlikely that our observed inverse correlation was due entirely to
differences in allele frequencies between countries because a high proportion of people in
Germany, Norway, Sweden and the United States may have similar northern European
ancestry [34].
Findings from our report are not reconciled easily with those of O'Connor et al. [9], who
found that the number of cigarettes and nicotine intake has decreased in parallel among
American smokers participating in two cross-sectional comparisons. If ‘hardening’ of
smokers is occurring, one would have expected that serum nicotine would remain stable as
remaining smokers could ingest more nicotine through compensatory smoking even if their
number of cigarettes smoked per day decreased. However, O'Connor et al. did not assess
nicotine dependence directly using a multi-dimensional scale that would capture other
important aspects of dependence. The FTND scale is one of many instruments that is used to
assess degree of dependence, each with its own strengths and limitations.
We acknowledge the limitations of this report and do not interpret the findings as causal.
Smoking data were based on self-report and, for some studies, national smoking prevalence
estimates, rather than study smoking estimates, were used. West et al. tested whether
national smoking prevalence figures were accurate and found that underestimates of
smoking were minimal in the United States but significant for England and Poland [35]. If
this pattern occurred in these countries in this report, our correlation would have increased
slightly. The age intervals of smokers differed slightly between studies, and surveys were
conducted in different years. Also, the wording of the questionnaire in different languages
may have directed respondents to different cognitive representations. The response mode
appeared to differ between face-to-face interviews, telephone interview and mailed
questionnaires. If these differences resulted in non-differential misclassification our results
would be biased towards the null value, and our ability to detect a correlation would be
blurred [36]. Finally, all samples were cross-sectional, so it was not possible to examine
changes in dependence and smoking prevalence over time.
Despite these limitations, our analysis of FTND score and smoking prevalence across 13
countries supports the hypothesis that remaining smokers may be hardening. Less dependent
smokers may quit more easily and remaining highly dependent smokers may need more
intensive treatment.
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Table 2
Fagerström Test for Nicotine Dependence (FTND) scores and smoking prevalence by country.
Author (reference number) Country Survey year FTND score Smoking prevalence
John [20] Germany 1997 2.8 37%
Kraft [21] Norway 1995 2.8 30%
deLeon [15] Spain 1997 2.9 38%
Vink [26] Netherlands 2000 2.9 26%
Danish Office [14] Denmark 1994 3.0 39%
Gallus [18] Italy 2002 3.1 27%
LaGrue [23] France 1987 3.4 37%
Puska [24] Finland 1994 3.5 23%
Zatonski† Poland 1993 3.6 36%
West* England 2007 3.0 25%
Kunze [22] Austria 1994 3.6 33%
Hellebush [19] USA 1993 4.3 26%
Furberg [16] USA 1992–98 4.4 20%‡
Shiffman [25] USA 1999 4.6 19%‡
Furberg [17] Sweden 1998–2002 4.6 16%
*
R. West, personal communication 2007, robert.west@ucl.ac.uk.
†
W. Zatonski, personal communication 1994, zatonskiw@coi.waw.pl.
‡
Smoking prevalence estimate obtained from the Centers for Disease Control tobacco statistics website for year of study.
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